Tandem Diabetes Care, Inc. Accounts Receivable, Allowance for Credit Loss
Tandem Diabetes Care, Inc. (TNDM) had Accounts Receivable, Allowance for Credit Loss of $7.89 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Accounts Receivable, after Allowance for Credit Loss
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2026-08-06
- 2026-06-30: Accounts Receivable, Allowance for Credit Loss $7.89M.
- 2026-03-31: Accounts Receivable, Allowance for Credit Loss $6.91M.
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss $8.39M.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss $7.56M.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2026-06-30 | $7.89M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $6.91M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $8.39M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $7.56M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $6.09M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $7.13M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $7.25M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $6.06M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $5.22M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $4.92M 10-Q · filed 2025-08-06 |
| 2023-12-31 | $4.90M 10-K · filed 2026-02-19 |
| 2023-09-30 | $5.36M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $4.84M 10-Q · filed 2024-11-06 |
| 2023-03-31 | $4.47M 10-Q · filed 2024-08-01 |
| 2022-12-31 | $4.33M 10-K · filed 2026-02-19 |
| 2022-09-30 | $4.27M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $4.60M 10-Q · filed 2023-11-01 |
| 2022-03-31 | $4.34M 10-Q · filed 2023-08-03 |
| 2021-12-31 | $4.25M 10-K · filed 2025-02-26 |
| 2021-09-30 | $3.79M 10-Q · filed 2022-11-02 |
| 2021-06-30 | $3.67M 10-Q · filed 2022-11-02 |
| 2021-03-31 | $3.56M 10-Q · filed 2022-08-03 |
| 2020-12-31 | $3.86M 10-K · filed 2024-02-21 |
| 2020-09-30 | $3.46M 10-Q · filed 2021-11-03 |
| 2020-06-30 | $3.14M 10-Q · filed 2021-11-03 |
| 2020-03-31 | $3.38M 10-Q · filed 2021-08-04 |
| 2019-12-31 | $3.30M 10-K · filed 2023-02-22 |
| 2019-09-30 | $2.69M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $2.19M 10-Q · filed 2020-11-05 |
| 2019-03-31 | $2.02M 10-Q · filed 2020-07-30 |
| 2018-12-31 | $1.84M 10-K · filed 2022-02-22 |
| 2017-12-31 | $1.03M 10-K · filed 2021-02-24 |
| 2016-12-31 | $735.00K 10-K · filed 2020-02-24 |
| 2015-12-31 | $221.00K 10-K · filed 2019-02-26 |
| 2014-12-31 | $253.00K 10-K · filed 2018-03-01 |
| 2013-12-31 | $218.00K 10-K · filed 2017-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |